Multiple high-resolution serum proteomic features for ovarian cancer detection
2 Assignments
0 Petitions
Accused Products
Abstract
A well-controlled serum study set (n=248) from women being followed and evaluated for the presence of ovarian cancer was used to extend serum proteomic pattern analysis to a higher resolution mass spectrometer instrument platform to explore the existence of multiple distinct highly accurate diagnostic sets of features present in the same mass spectrum. Multiple highly accurate diagnostic proteomic feature sets exist within human sera mass spectra. Using high-resolution mass spectral data, at least 56 different patterns were discovered that achieve greater than 85% sensitivity and specificity in testing and validation. Four of those feature sets exhibited 100% sensitivity and specificity in blinded validation. The sensitivity and specificity of diagnostic models generated from high-resolution mass spectral data were superior (P<0.00001) than those generated from low-resolution mass spectral data using the same input sample.
-
Citations
12 Claims
-
1-5. -5. (canceled)
-
6. A method of determining whether a biological sample taken from a subject indicates that the subject has a disease by analyzing a data stream that is obtained by performing an analysis of the biological sample, the data stream having a first number of data points, comprising:
-
condensing the data stream such that the condensed data stream has a second number of data points, the second number being less than the first number of data points;
abstracting the condensed data stream to produce a sample vector that characterizes the condensed data stream in a predetermined vector space containing a diagnostic cluster, the diagnostic cluster being a disease cluster, the disease cluster corresponding to the presence of the disease;
determining whether the sample vector rests within the disease cluster; and
if the sample vector rests within the diseased cluster, identifying the biological sample as indicating that the subject has the disease. - View Dependent Claims (7, 8, 9, 10, 11, 12)
-
Specification